Activation of the -opioid receptor in Caco-2 cells decreases interleukin-8 secretion

By Neudeck B.L.   Loeb J.   Buck J.  

European Journal of Pharmacology, Vol. 467, Iss. 1, 2003-04 ,pp. : 81-84

Elsevier

Access to resources Recommend Favorite

Interleukin-1 antagonists for diabetes

By Mandrup-Poulsen Thomas  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 8, 2013-08 ,pp. : 965-979

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-1 receptor antagonists appear to have a role to play in treating inflammatory diseases

By  

Inpharma, Vol. 1, Iss. 1255, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

(E)-1-(Heterocyclyl or cyclohexyl)-2-[1,3,7-trisubstituted (xanthin-8-yl)] ethenes as A 2a adenosine receptor antagonists

By Del Giudice M.   Borioni A.   Mustazza C.   Gatta F.   Dionisotti S.   Zocchi C.   Ongini E.  

European Journal of Medicinal Chemistry, Vol. 31, Iss. 1, 1996-01 ,pp. : 59-63

Elsevier

Access to resources Recommend Favorite

Synthesis of 3- and 5'-substituted flavone-8-carboxylic acids as 'three-armed' leukotriene CysLT 1 receptor antagonists

By Zwaagstra M.E.   Korthouwer R.E.M.   Timmerman H.   Zhang M.-Q.  

European Journal of Medicinal Chemistry, Vol. 33, Iss. 2, 1998-02 ,pp. : 95-102

Elsevier

Access to resources Recommend Favorite